This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: h6 (identification of evaluation codes 10, 11, 3331, 180, 22).Method code #1: 10 - testing of actual/suspected device, method code #2: 11 - testing of device from same lot/batch retained by manufacturer, method code #3: 3331 - analysis of production records, results code: 180 - mechanical problem identified, conclusions code: 22 - known inherent risk of device.The returned samples were visually inspected and it was confirmed that the luers were sufficiently inserted into the reservoir ports, however, the customer supplied samples continued to spin about the threads without ever locking around them.The luered ports on the reservoir lid are checked in process for the internal sealing taper, using a calibrated luer gauge.However, there are luer ports on the reservoir that only have half threads.The connectors supplied by the customer do not lock on these ports.The luer ports were not designed with full threads.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on april 18, 2019.Upon further investigation of the reported event, the following information is new and/or changed: b5 (describe event or problem).G4 (date received by manufacturer).G7 (indication that this is a follow-up report).H2 (follow-up due to correction).A second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusions code 11.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|